RELIV INTERNATIONAL INC - Quarter Report: 2013 March (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________

FORM 10-Q

(Mark One)

For the transition period from _________to_________

Commission File Number

000-19932

RELIV’ INTERNATIONAL, INC.

(Exact name of Registrant as specified in its charter)

(636) 537-9715

(Registrant’s telephone number, including area code)

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ     No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes þ     No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o     Accelerated filer o      Non-accelerated filer o Smaller reporting company  þ

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o     No þ

The number of shares outstanding of the Registrant’s common stock as of April 30, 2013 was 12,615,595 (excluding treasury shares).

INDEX

Reliv International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

March 31, 2013

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements and notes thereto have been prepared in accordance with the instructions to Form 10-Q and reflect all adjustments (which primarily include normal recurring accruals) which management believes are necessary to present fairly the financial position, results of operations and cash flows. These statements, however, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Interim results may not necessarily be indicative of results that may be expected for any other interim period or for the year as a whole. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the annual report on Form 10-K for the year ended December 31, 2012, filed March 26, 2013 with the Securities and Exchange Commission.

Basic earnings per common share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the weighted average number of common shares and potential dilutive common shares that were outstanding during the period. Potential dilutive common shares consist of outstanding stock options, outstanding stock warrants, and convertible preferred stock.

Options and warrants to purchase 1,287,125 and 1,243,863 shares of common stock for the three months ended March 31, 2013 and 2012, respectively, were not included in the denominator for diluted earnings per share because their effect would be antidilutive or because the shares were deemed contingently issuable.

Reliv International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

March 31, 2013

In March 2013, the Company issued performance based stock option grants totaling 230,000 shares. These option grants have an exercise price of $1.17 per share with a five-year term. The options' vesting provisions are contingent upon the Company achieving certain financial performance measurements. The aggregate estimated compensation cost related to the performance based options is $110,400; however, recognition is contingent upon performance vesting. The grant-date fair value of the options is $0.48 per share and was determined using a binomial option pricing model using an average risk-free rate of 0.90%, an average dividend yield of 1.60%, and an average volatility of 52.7%.

The Company recognized stock-based compensation expense from all plans of approximately $11,661 and $53,277 in the three months ended March 31, 2013 and 2012, respectively. This expense is presented in Selling, General and Administrative in the accompanying condensed consolidated statements of net income and comprehensive income.

Fair value can be measured using valuation techniques such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those levels:

Reliv International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

March 31, 2013

Originating in September 2012 with its primary lender, the term loan is for a period of thirty-eight months with interest accruing at a floating interest rate based on the 30-day LIBOR plus 2%. At March 31, 2013, the term loan's interest rate was 2.2037%. Monthly principal and interest are based on approximately a seven-year amortization. The aggregate outstanding balance of principal and interest is due and payable on November 30, 2015. The Company also has a $5 million revolving loan agreement with its primary lender. There have not been any revolver borrowing in 2013.

The term loan agreement and the revolving line of credit agreement are secured by all tangible and intangible assets of the Company and also by a mortgage on the real estate of the Company's headquarters. These agreements also include loan covenants requiring the Company to maintain net tangible worth of not less than $11 million, and that borrowings under the agreements shall not exceed EBITDA by a ratio of 2.5 to 1. At March 31, 2013, the Company was in compliance with its loan covenants.

The Company's remaining obligation for purchase of a distributorship requires payments of principal and interest of $37,500 per month through June 2013.

In March 2012, the Company purchased from a real estate investment management firm a note and mortgage ("Note") on certain properties in Wyoming and Idaho for $2 million. In May 2012, the Company entered into a Loan Modification Agreement ("LMA") with the Note's original and present borrower ("Borrower") to restructure the Note's principal amount due and related terms. The LMA terms are for a principal balance due of $2 million with interest only payable monthly in 2012. The LMA's interest rate is the greater of 6% or prime and there is no prepayment penalty for voluntary principal payments. Concurrently, with the execution of of the LMA, the Company and the Borrower also entered into a Security Agreement in which repayment of the LMA is secured by the Borrower's Reliv distributorship business.

As originally structured, beginning in 2013, the LMA was to require monthly payment of principal and interest under a five-year amortization period. In the first quarter of 2013, while a permanent restructuring of the LMA's repayment terms are being negotiated, management and the Borrower have verbally agreed to a temporary LMA modification which prospectively requires the Borrower to make monthly payments of principal and interest under a fifteen-year amortization period. The outstanding balance of the note receivable was $1,985,965 and $2,000,000 as of March 31,2013 and December 31, 2012, respectively.

Reliv International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

March 31, 2013

One of the Company's foreign subsidiaries is presently under local country audit for alleged deficiencies (totaling approximately $800,000 plus interest at 20% per annum) in value-added tax (VAT) and withholding tax for the years 2004 through 2006. The Company, in consultation with its legal counsel, believes that there are strong legal grounds that it should not be liable to pay the majority of the alleged tax deficiencies. As of December 31, 2010, management estimated and reserved approximately $185,000 for resolution of this matter and recorded this amount within Selling, General, and Administrative expense in the 2010 Consolidated Statement of Income. In 2011, the Company has made good faith deposits to the local tax authority under the tax agency's administrative judicial resolution process. As of March 31, 2013 and December 31, 2012, management's estimated reserve (net of deposits) for this matter is approximately $70,000. There has been no change in this matter during the first three months of 2013.

FORWARD-LOOKING STATEMENTS

This quarterly report includes both historical and “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. We have based these forward-looking statements on our current expectations and projections about future results. Words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar words are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Although we believe that our opinions and expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and our actual results may differ substantially from the views and expectations set forth in this quarterly report on Form 10-Q. We disclaim any intent or obligation to update any forward-looking statements after the date of this annual report to conform such statements to actual results or to changes in our opinions or expectations.

Item No. 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q. The following discussion and analysis discusses the financial condition and results of our operations on a consolidated basis, unless otherwise indicated.

Overview

We are a developer, manufacturer and marketer of a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management and sports nutrition. We also offer a line of skin care and food products under our Relivables brand. We sell our products through an international network marketing system utilizing independent distributors. Sales in the United States represented approximately 80.1% of worldwide net sales for the three months ended March 31, 2013 and 79.9% of worldwide net sales for the three months ended March 31, 2012. Our international operations currently generate sales through distributor networks with facilities in Australia, Canada, Indonesia, Malaysia, Mexico, the Philippines, and the United Kingdom. We also operate on remotely in Ireland, France, Germany, Austria and the Netherlands from our U.K. distribution center, in New Zealand from our Australia office, and in Singapore and Brunei from our Malaysia office.

We derive our revenues principally through product sales made by our global independent distributor base, which, as of March 31, 2013, consisted of approximately 56,040 distributors. Our sales can be affected by several factors, including our ability to attract new distributors and retain our existing distributor base, our ability to properly train and motivate our distributor base and our ability to develop new products and successfully maintain our current product line.

All of our sales to distributors outside the United States are made in the respective local currency; therefore, our earnings and cash flows are subject to fluctuations due to changes in foreign currency rates as compared to the U.S. dollar. As a result, exchange rate fluctuations may have an effect on sales and gross margins. United States generally accepted accounting practices require that our results from operations be converted to U.S. dollars for reporting purposes. Consequently, our reported earnings may be significantly affected by fluctuations in currency exchange rates, generally increasing with a weaker U.S. dollar and decreasing with a strengthening U.S. dollar. Products manufactured by us for sale to our foreign subsidiaries are transacted in U.S. dollars. From time to time, we enter into foreign exchange forward contracts to mitigate our foreign currency exchange risk.

Components of Net Sales and Expense

Product sales represent the actual product purchase price typically paid by our distributors, after giving effect to distributor allowances, which can range from 20% to 40% of suggested retail price, depending on the rank of a particular distributor. Handling and freight income represents the amounts billed to distributors for shipping costs. We record net sales and the related commission expense when the merchandise is shipped.

Our primary expenses include cost of products sold, distributor royalties and commissions and selling, general and administrative expenses.

Cost of products sold primarily consists of expenses related to raw materials, labor, quality control and overhead directly associated with production of our products and sales materials, as well as shipping costs relating to the shipment of products to distributors, and duties and taxes associated with product exports. Cost of products sold is impacted by the cost of the ingredients used in our products, the cost of shipping distributors’ orders, along with our efficiency in managing the production of our products.

Distributor royalties and commissions are monthly payments made to distributors, based on products sold in their downline organization. Based on our distributor agreements, these expenses have typically approximated 23% of sales at suggested retail. In the United States effective March 1, 2013, we instituted a retail price increase, offset by a reduced shipping charge. After the price change, wholesale pricing discounts on distributor orders are based on the retail value of the product. Distributor royalties and commissions are paid on an amount referred to as the business value (“BV”), which is generally equal to the retail price of each product prior to the price increase. Also, we include other sales leadership bonuses, such as Ambassador bonuses, within this caption. Overall, distributor royalties and commissions remain directly related to the level of our sales and should continue at comparable levels as a percentage of net sales going forward.

Selling, general and administrative expenses include the compensation and benefits paid to our employees except for those in manufacturing, all other selling expenses, marketing, promotional expenses, travel and other corporate administrative expenses. These other corporate administrative expenses include professional fees, non-manufacturing depreciation and amortization, occupancy costs, communication costs and other similar operating expenses. Selling, general and administrative expenses can be affected by a number of factors, including staffing levels and the cost of providing competitive salaries and benefits; the amount we decide to invest in distributor training and motivational initiatives; and the cost of regulatory compliance.

Results of Operations

     The following table sets forth selected results of our operations expressed as a percentage of net sales for the three-month periods ended March 31, 2013 and 2012. Our results of operations for the periods described below are not necessarily indicative of results of operations for future periods.

Net Sales. Overall net sales decreased by 4.5% in the three months ended March 31, 2013 compared to the same period in 2012. During the first quarter of 2013, sales in the United States decreased by 4.2%, and international sales decreased by 5.7% over the prior-year period.

     The following table summarizes net sales by geographic market for the three months ended March 31, 2013 and 2012.

The following table sets forth, as of March 31, 2013 and 2012, the number of our active distributors and Master Affiliates and above. The total number of active distributors includes Master Affiliates and above. We define an active distributor as one that enrolls as a distributor or renews his or her distributorship during the prior twelve months. Master Affiliates and above are distributors that have attained the highest level of discount and are eligible for royalties generated by Master Affiliate groups in their downline organization.

In the United States, net sales were down 4.2% in the first quarter of 2013 compared to the same period in 2012. Sales declined in the first quarter of 2013 as distributor activity and the number of new and requalifying Master Affiliates and above in the United States continued to decline. This decline is shown in the form of a decrease in the number of active distributors and distributors at the level of Master Affiliate and above, along with a decrease in the number of new distributor enrollments. The net number of active distributors in the United States as of March 31, 2013 decreased by 6.7% to 40,020, compared to the number of active distributors as of March 31, 2012. The net number of distributors at the level of Master Affiliate and above as of March 31, 2013 decreased by 13.0% as compared to March 31, 2012, as fewer distributorships qualified as new Master Affiliates and fewer requalified by January 2013 to retain their status as a Master Affiliate. In the first quarter of 2013, approximately 358 distributors qualified as new Master Affiliates, compared to approximately 400 in the prior-year quarter, a decline of 10.5%. During the first quarter of 2013, approximately 2,781 new distributors were enrolled, compared to 3,023 new distributor enrollments in the prior-year quarter, a decline of 8.0%. Distributor retention declined to 64.2% for the first three months of 2013 compared to a rate of 66.5% for all of 2012.

In the first quarter of 2013, we processed approximately 54,317 orders in the United States for products at an average order of $376 at suggested retail. In the same period of 2012, we processed approximately 59,012 product orders at an average order of $356 at suggested retail. The decline in the number of orders processed is attributable to the decline in distributor activity; however, the increase in the average order size is attributable to product orders in advance of the increase in our retail pricing and adjustment to our freight charge structure effective March 1, 2013.

Along with the pricing/freight charge restructuring, our efforts in the United States to increase distributor activity and ordering focuses on product innovation. We continue to focus our product developments on our LunaRich™-based products. In January 2013, we launched our latest product, LunaRich X, and a new points-based LunaRich wellness system. LunaRich X is a capsule sold in 30-count bottles and contains the most concentrated form of lunasin currently available. Lunasin is the peptide scientists have identified as the key to many of soy’s documented health benefits. LunaRich X accounted for 7.2 percent of U.S. net sales in the first quarter of 2013.

During the three months ended March 31, 2013, net sales in our international operations decreased in aggregate by 5.7% to $3.75 million compared to $3.97 million for the three months ended March 31, 2012. When measured on a constant currency basis, sales increased in Europe and slightly in Canada, but were offset by declines in Australia/New Zealand, Mexico, and Asia during the first quarter of 2013. When net sales are converted using the 2012 exchange rate for both 2012 and 2013, international net sales decreased by 5.6% for the first quarter of 2013 compared to the first quarter of the prior year. Regional sales results on a constant currency basis for the first quarter of 2013 compared to the first quarter of 2012 were as follows: Australia/New Zealand net sales decreased 16.4%, Canada net sales increased 1.3%, Mexico net sales decreased 5.5%, Europe net sales increased 28.0%, and Asian sales decreased 57.3%.

In Europe, strong distributor activity and growth continued in the first quarter of 2013 and resulted in a 28.0% increase in net sales. Total order count increased to 5,268 in the first quarter of 2013 compared to 4,562 in the same period last year, an increase of 15.5%. Other distributor statistics remained strong, with new distributor enrollments of 1,344 in the first quarter of 2013, compared to 1,424 in the same period in 2012; and new Master Affiliate qualifications were 150 in the first quarter of 2013, compared to 148 in the same period in 2012.

In Asia, sales declined as the result of an on-going transition of the business model in the region and changes in management in certain of the local markets. In the Philippines, we have introduced initiatives to bring in new Master Affiliates at a lower qualification level and to increase focus on retail sales by distributors. However, sales have declined while implementation and distributor training of these initiatives is in process. On a constant currency basis, sales in the Philippines declined by 60.7% in the first quarter of 2013 compared to the prior year quarter. In the Malaysia/Singapore/Brunei markets, similar changes are being introduced and in April 2013 we hired a new sales manager for these markets. In these markets, sales have declined by 32.1% in the first quarter of 2013 compared to the prior-year quarter.

In Australia/New Zealand, sales declined by 16.4% in the first quarter of 2013 compared to the prior-year quarter. To improve sales in that region, we have implemented pricing and freight charge structure changes similar to the United States in May 2013 along with other initiatives. Additionally, we hired a new sales manager late in the fourth quarter of 2012.

Cost of Products Sold. Cost of products sold as a percentage of net sales was 20.7% for the three-month period ended March 31, 2013, compared to 19.8% for the same period in 2012. Gross margins decreased in the first quarter of 2013 as the result of increases in the cost of various raw materials and other production costs.

Distributor Royalties and Commissions. Distributor royalties and commissions as a percentage of net sales was 37.1% for the three-month period ended March 31, 2013, compared to 37.7% in the same period in 2012. The decrease as a percentage of net sales is the result of the retail price increase and commission restructuring effective March 1, 2013 in the United States. After the price change, wholesale discounts on distributor orders are based on the retail value of the product. Distributor royalties and commissions are paid on an amount referred to as the business value (“BV”), which is generally equal to the retail price of each product prior to the price increase.

Selling, General and Administrative Expenses. For the three months ended March 31, 2013, selling, general and administrative expenses (“SGA”) increased by $41,000, compared to the same period in 2012. SGA expenses as a percentage of net sales were 39.9% for the three-month period ended March 31, 2013, compared to 37.9% for the same period of 2012.

Sales and marketing expenses increased by approximately $61,000 in the first quarter of 2013, compared to the prior-year quarter. The aggregate increase included advertising/public relations expenses of $90,000, as we engaged in public relations efforts to bring greater awareness to the LunaRich product line and lunasin, in general. Our promotions expense increased by $80,000 primarily related to an increase in participants in a February incentive trip from Europe. These increases were offset in a decrease in distributor bonuses and other expenses directly related to the level of sales of approximately $69,000.

Salaries, benefits, and incentive compensation remained steady in the first quarter of 2013, compared to the prior-year quarter, as increases in salaries and benefit expenses of approximately $103,000 were offset by a decrease in incentive compensation expense of $102,000. Distribution and warehouse expenses decreased by $32,000 and other general and administrative expenses increased by approximately $11,000 in the first quarter of 2013, compared to the prior-year quarter. The increase in other general and administrative expenses included a charge for $44,000 in compensation expense recognized as part of a long-term incentive agreement with our management team in our European subsidiary.

Interest Income. Interest income increased to $37,000 during the first quarter of 2013 compared to $9,000 in the first quarter of 2012. The increase in interest income is the result of interest earned on the note receivable due from a distributor that was entered into in March 2012.

Interest Expense. Interest expense decreased to $18,000 during the first quarter of 2013 compared to $31,000 in the first quarter of 2012. The lower interest expense is the result of a decrease in the amount of debt compared to the prior year.

Other Income/Expense. Other income/expense in the first quarter of 2013 was a net expense of $27,000, compared to a net expense of $23,000 in the first quarter of 2012. The net expense in the first quarter in each year is primarily the result of foreign currency exchange losses in certain of our subsidiaries.

Income Taxes. We recorded income tax expense of $233,000 for the first three months of 2013, resulting in an effective rate of 54.5%. In the same period in 2012, we recorded income tax expense of $337,000, which represented an effective rate of 38.8%. Our effective rate is higher in 2013 due to losses incurred in the Philippines in the quarter for which there is no tax benefit.

Net Income. Our net income for the three months ended March 31, 2013 was approximately $195,000 ($0.02 per share basic and diluted), compared to approximately $532,000 ($0.04 per share basic and diluted) for the same period in 2012. Profitability decreased in the first quarter of 2013 as the result of the sales decreases and additional investments in staffing in Asia and Australia/New Zealand, coupled with the continued decrease in net sales in the United States as discussed above.

Financial Condition, Liquidity and Capital Resources

During the first three months of 2013 , we generated $609,000 of net cash from operating activities, $307,000 was used in investing activities, and we used $212,000 in financing activities. This compares to $1.77 million of net cash provided by operating activities, $2.32 million used in investing activities, and $154,000 used in financing activities in the same period of 2012. Cash and cash equivalents increased by $64,000 to $5.87 million as of March 31, 2013 compared to December 31, 2012.

Significant changes in working capital items consisted of an increase in inventory of $138,000, an increase in prepaid expenses/other current assets of $740,000, an increase in accounts payable and accrued expenses of $853,000, and an increase in income taxes payable of $156,000 in the first three months of 2013. The increase in inventory is to support the sales growth in Europe, and the increase in prepaid expenses/other current assets represents the annual premium payments made in the first quarter on most of the corporate insurance policies. The increase in accounts payable and accrued expenses is partially related to a financing arrangement for our annual corporate insurance policy renewals, coupled with various annual accruals and the increase in inventory. The increase in income taxes payable is a function of the timing of estimated tax payments.

Investing activities during the first three months of 2013 consisted of a net investment of $61,000 for capital expenditures, payments received on a distributor note receivable of $14,000, and $260,000 for key-man life insurance. Financing activities during the first three months of 2013 consisted of principal payments of $212,000 on long-term borrowings.

Stockholders’ equity increased to $15.77 million at March 31, 2013 compared to $15.58 million at December 31, 2012. The increase is due to our net income during the first three months of 2013 of $195,000 and a decline in the cumulative foreign currency translation adjustment of $17,000 due to the general weakening of the United States dollar. Our working capital balance was $5.89 million at March 31, 2013 compared to $5.88 million at December 31, 2012. The current ratio at March 31, 2013 was 1.79 compared to 1.89 at December 31, 2012.

On September 30, 2012, we entered into a term loan with our primary lender (“the Bank”) in the principal amount of $2.9 million. The loan was renegotiated from a loan that originated with the Bank on November 30, 2010. The term of the loan is for a period of three years and two months with interest accruing on the outstanding principal balance at a floating interest rate based on the 30-day LIBOR plus 2.0%. Monthly principal and interest payments are based on approximately a seven-year amortization. The aggregate outstanding balance of principal and interest is due and payable on November 30, 2015.

We also renewed a revolving credit facility for $5 million with the Bank in September 2012. The credit facility accrues interest on the outstanding principal balance at a floating interest rate based on 30-day LIBOR plus 1.85% and has a maturity date of September 30, 2013. As of March 31, 2013, there were no outstanding borrowings on the revolving credit facility.

The amended terms of the term loan and revolving credit facility are reflected in separate promissory notes dated September 30, 2012 between us and the Bank. A separate letter agreement stating the financial covenants related to the term loan and revolving credit facility was updated and amended on April 4, 2012 and continues in effect.

Under the terms of the amended letter agreement, we have agreed to financial covenants under which we are required to (i) maintain at all times a tangible net worth of not less than $11 million and (ii) maintain at all times a ratio of Total Funded Debt to EBITDA of not greater than 2.5 to 1. The term loan and revolving credit facility are secured by all of our tangible and intangible assets and also by a mortgage on our building and real estate located in Chesterfield, Missouri. As of March 31, 2013, we were in compliance with all financial covenants.

Management believes that our internally generated funds coupled with cash on hand and the bank loan facilities will be sufficient to meet working capital requirements for the remainder of 2013.

Critical Accounting Policies

A summary of our critical accounting policies and estimates is presented on pages 25-26 of our 2012 Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 26, 2013.

Item No. 4 - Controls and Procedures

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has reviewed and evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2013. Based on such review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of March 31, 2013, to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, (a) is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms and (b) is accumulated and communicated to our management, including the officers, as appropriate to allow timely decisions regarding required disclosure. There were no material changes in our internal control over financial reporting during the first quarter of 2013 that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

PART II – OTHER INFORMATION

Item No. 6 – Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 15, 2013